The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence
Open accessAbstract
Chronic obstructive pulmonary disease (COPD) is characterised by an inflammatory response by the lungs to inhaled substances such as cigarette smoking and air pollutants. In addition to the pulmonary features of COPD, several systemic effects have been recognised even after controlling for common aetiological factors such as smoking or steroid use. These include skeletal muscle dysfunction, cardiovascular disease, osteoporosis and diabetes. Individuals with COPD have significantly raised levels of several circulating inflammatory markers indicating the presence of systemic inflammation. This raises the issue of cause and effect. The role of tumour necrosis factor α in COPD is thought to be central to both lung and systemic inflammation and has been implicated in skeletal muscle dysfunction, osteoporosis and type 2 diabetes. It has been hypothesised that inflammation in the lung results in 'overspill' into the circulation causing systemic inflammation. There is supportive evidence that protein movement can occur from the lung surface to the systemic circulation. Evidence from inhaled substances such as air pollutants and cigarette smoke has demonstrated a temporal link between the inflammatory process in the lung and systemic inflammation. Also, studies have shown alterations in circulating inflammatory cells in patients with COPD compared with controls which may reflect the effects of inflammatory mediators (derived from the lung) on circulating cells or the bone marrow. This paper considers the concept of 'overspill' in depth, reviews the current evidence and highlights problems in generating direct evidence to support or refute this concept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Mechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,166
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
SALVI, S., BLOMBERG, A., RUDELL, B., KELLY, F., SANDSTRÖM, T., HOLGATE, S. T., & FREW, A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9709083 · Cited by 899
The Relationship Between Reduced Lung Function and Cardiovascular Mortality
Sin, D. D., Wu, L., & Man, S. F. P. (2005) · Chest · doi:10.1378/chest.127.6.1952 · Cited by 881
Cited by
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Hypoxemia in patients with COPD: cause, effects, and disease progression
McNicholas, W., Kent, & Mitchell (2011) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s10611 · Cited by 434
Pulmonary-intestinal cross-talk in mucosal inflammatory disease
Keely, S., Talley, N. J., & Hansbro, P. M. (2012) · Mucosal Immunology · doi:10.1038/mi.2011.55 · Cited by 386
Anxiety and depression-Important psychological comorbidities of COPD.
Pumar, M., Gray, C. R., Walsh, J., Yang, I. A., Rolls, T., & Ward, D. L. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.09.28 · Cited by 272
Jhee, J. H., Joo, Y. S., Kee, Y. K., Jung, S.-Y., Park, S., Yoon, C.-Y., Han, S. H., Yoo, T.-H., Kang, S.-W., & Park, J. T. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09540818 · Cited by 60
“As inflammation and oxidative stress in the lungs have been found to affect the circulatory system, resulting in an increase in systemic oxidative stress (36), there is a possibility that secondhand smoke–induced respiratory reactive oxidative species could have resulted in kidney damage.”
BackgroundTNF-α Is Associated with Loss of Lean Body Mass Only in Already Cachectic COPD Patients
Eagan, T. M., Gabazza, E. C., D’Alessandro-Gabazza, C., Gil-Bernabe, P., Aoki, S., Hardie, J. A., Bakke, P. S., & Wagner, P. D. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-48 · Cited by 39
“However, the measured levels of TNF-α in BAL and blood correlate poorly [13], and some studies have not found higher levels of TNF-α in COPD patients with cachexia compared with patients without cachexia [19,20,22].”
Background
Metadata
- Authors
- Sinden, N. J., & Stockley, R. A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2010-07-13
- Volume
- 65
- Issue
- 10
- Pages
- 930-936
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2100277531
- Cited by
- 379
- References
- 80
- FWCI
- 19.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.